These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
324 related articles for article (PubMed ID: 29787357)
1. Prophylactic Cranial Irradiation Versus Observation in Radically Treated Stage III Non-Small-Cell Lung Cancer: A Randomized Phase III NVALT-11/DLCRG-02 Study. De Ruysscher D; Dingemans AC; Praag J; Belderbos J; Tissing-Tan C; Herder J; Haitjema T; Ubbels F; Lagerwaard F; El Sharouni SY; Stigt JA; Smit E; van Tinteren H; van der Noort V; Groen HJM J Clin Oncol; 2018 Aug; 36(23):2366-2377. PubMed ID: 29787357 [TBL] [Abstract][Full Text] [Related]
2. Randomized phase III trial of prophylactic cranial irradiation versus observation in patients with fully resected stage IIIA-N2 nonsmall-cell lung cancer and high risk of cerebral metastases after adjuvant chemotherapy. Li N; Zeng ZF; Wang SY; Ou W; Ye X; Li J; He XH; Zhang BB; Yang H; Sun HB; Fang Q; Wang BX Ann Oncol; 2015 Mar; 26(3):504-9. PubMed ID: 25515658 [TBL] [Abstract][Full Text] [Related]
3. Health-related quality of life after prophylactic cranial irradiation for stage III non-small cell lung cancer patients: Results from the NVALT-11/DLCRG-02 phase III study. Witlox WJA; Ramaekers BLT; Joore MA; Dingemans AC; Praag J; Belderbos J; Tissing-Tan C; Herder G; Haitjema T; Ubbels JF; Lagerwaard J; El Sharouni SY; Stigt JA; Smit EF; van Tinteren H; van der Noort V; Groen HJM; De Ruysscher DKM Radiother Oncol; 2020 Mar; 144():65-71. PubMed ID: 31733490 [TBL] [Abstract][Full Text] [Related]
4. Prophylactic Cranial Irradiation vs Observation in Patients With Locally Advanced Non-Small Cell Lung Cancer: A Long-term Update of the NRG Oncology/RTOG 0214 Phase 3 Randomized Clinical Trial. Sun A; Hu C; Wong SJ; Gore E; Videtic G; Dutta S; Suntharalingam M; Chen Y; Gaspar LE; Choy H JAMA Oncol; 2019 Jun; 5(6):847-855. PubMed ID: 30869743 [TBL] [Abstract][Full Text] [Related]
5. Treatment and toxic effects of prophylactic cranial irradiation in stage II-III non-small cell lung cancer: A meta-analysis. Li M; Wang T; Wen P; Wang X; Wu C Asia Pac J Clin Oncol; 2021 Apr; 17(2):e18-e26. PubMed ID: 32761788 [TBL] [Abstract][Full Text] [Related]
6. Phase III comparison of prophylactic cranial irradiation versus observation in patients with locally advanced non-small-cell lung cancer: primary analysis of radiation therapy oncology group study RTOG 0214. Gore EM; Bae K; Wong SJ; Sun A; Bonner JA; Schild SE; Gaspar LE; Bogart JA; Werner-Wasik M; Choy H J Clin Oncol; 2011 Jan; 29(3):272-8. PubMed ID: 21135270 [TBL] [Abstract][Full Text] [Related]
7. Rates of Overall Survival and Intracranial Control in the Magnetic Resonance Imaging Era for Patients With Limited-Stage Small Cell Lung Cancer With and Without Prophylactic Cranial Irradiation. Pezzi TA; Fang P; Gjyshi O; Feng L; Liu S; Komaki R; Lin SH JAMA Netw Open; 2020 Apr; 3(4):e201929. PubMed ID: 32236532 [TBL] [Abstract][Full Text] [Related]
8. Prophylactic Cranial Irradiation for Patients With Locally Advanced Non-Small-Cell Lung Cancer at High Risk for Brain Metastases. Park HS; Decker RH; Wilson LD; Yu JB Clin Lung Cancer; 2015 Jul; 16(4):292-7. PubMed ID: 25499149 [TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of prophylactic cranial irradiation in patients with small cell lung cancer. van de Pol M; ten Velde GP; Wilmink JT; Volovics A; Twijnstra A J Neurooncol; 1997 Nov; 35(2):153-60. PubMed ID: 9266453 [TBL] [Abstract][Full Text] [Related]
11. Prophylactic cranial irradiation versus observation in patients with extensive-disease small-cell lung cancer: a multicentre, randomised, open-label, phase 3 trial. Takahashi T; Yamanaka T; Seto T; Harada H; Nokihara H; Saka H; Nishio M; Kaneda H; Takayama K; Ishimoto O; Takeda K; Yoshioka H; Tachihara M; Sakai H; Goto K; Yamamoto N Lancet Oncol; 2017 May; 18(5):663-671. PubMed ID: 28343976 [TBL] [Abstract][Full Text] [Related]
12. Icotinib versus whole-brain irradiation in patients with EGFR-mutant non-small-cell lung cancer and multiple brain metastases (BRAIN): a multicentre, phase 3, open-label, parallel, randomised controlled trial. Yang JJ; Zhou C; Huang Y; Feng J; Lu S; Song Y; Huang C; Wu G; Zhang L; Cheng Y; Hu C; Chen G; Zhang L; Liu X; Yan HH; Tan FL; Zhong W; Wu YL Lancet Respir Med; 2017 Sep; 5(9):707-716. PubMed ID: 28734822 [TBL] [Abstract][Full Text] [Related]
13. Phase III trial of prophylactic cranial irradiation compared with observation in patients with locally advanced non-small-cell lung cancer: neurocognitive and quality-of-life analysis. Sun A; Bae K; Gore EM; Movsas B; Wong SJ; Meyers CA; Bonner JA; Schild SE; Gaspar LE; Bogart JA; Werner-Wasik M; Choy H J Clin Oncol; 2011 Jan; 29(3):279-86. PubMed ID: 21135267 [TBL] [Abstract][Full Text] [Related]
14. Prophylactic Cranial Irradiation Reduces Brain Metastases and Improves Overall Survival in High-Risk Metastatic Non-Small Cell Lung Cancer Patients: A Randomized phase 2 Study (PRoT-BM trial). Arrieta O; Maldonado F; Turcott JG; Zatarain-Barrón ZL; Barrón F; Blake-Cerda M; Cabrera-Miranda LA; Cardona AF; de la Garza JG; Rosell R Int J Radiat Oncol Biol Phys; 2021 Aug; 110(5):1442-1450. PubMed ID: 33640422 [TBL] [Abstract][Full Text] [Related]
15. Prophylactic cranial irradiation in locally advanced non-small cell lung cancer: outcome of recursive partitioning analysis group 1 patients. Yavuz AA; Topkan E; Onal C; Yavuz MN J Exp Clin Cancer Res; 2008 Dec; 27(1):80. PubMed ID: 19055787 [TBL] [Abstract][Full Text] [Related]
16. Incidence of symptomatic brain metastasis following radical radiotherapy for non-small cell lung cancer: is there a role for prophylactic cranial irradiation? Khan E; Ismail S; Muirhead R Br J Radiol; 2012 Dec; 85(1020):1546-50. PubMed ID: 22993386 [TBL] [Abstract][Full Text] [Related]
17. Standard-dose versus higher-dose prophylactic cranial irradiation (PCI) in patients with limited-stage small-cell lung cancer in complete remission after chemotherapy and thoracic radiotherapy (PCI 99-01, EORTC 22003-08004, RTOG 0212, and IFCT 99-01): a randomised clinical trial. Le Péchoux C; Dunant A; Senan S; Wolfson A; Quoix E; Faivre-Finn C; Ciuleanu T; Arriagada R; Jones R; Wanders R; Lerouge D; Laplanche A; Lancet Oncol; 2009 May; 10(5):467-74. PubMed ID: 19386548 [TBL] [Abstract][Full Text] [Related]
18. Individual patient data meta-analysis of prophylactic cranial irradiation in locally advanced non-small cell lung cancer. Witlox WJA; Ramaekers BLT; Lacas B; Le Pechoux C; Pignon JP; Sun A; Wang SY; Hu C; Redman M; van der Noort V; Li N; Guckenberger M; van Tinteren H; Groen HJM; Joore MA; De Ruysscher DKM Radiother Oncol; 2021 May; 158():40-47. PubMed ID: 33587968 [TBL] [Abstract][Full Text] [Related]
19. Randomized Phase III Trial of Prophylactic Cranial Irradiation With or Without Hippocampal Avoidance for Small-Cell Lung Cancer (PREMER): A GICOR-GOECP-SEOR Study. Rodríguez de Dios N; Couñago F; Murcia-Mejía M; Rico-Oses M; Calvo-Crespo P; Samper P; Vallejo C; Luna J; Trueba I; Sotoca A; Cigarral C; Farré N; Manero RM; Durán X; Gispert JD; Sánchez-Benavides G; Rognoni T; Torrente M; Capellades J; Jiménez M; Cabada T; Blanco M; Alonso A; Martínez-San Millán J; Escribano J; González B; López-Guerra JL J Clin Oncol; 2021 Oct; 39(28):3118-3127. PubMed ID: 34379442 [TBL] [Abstract][Full Text] [Related]
20. Prophylactic cranial irradiation in operable stage IIIA non small-cell lung cancer treated with neoadjuvant chemoradiotherapy: results from a German multicenter randomized trial. Pöttgen C; Eberhardt W; Grannass A; Korfee S; Stüben G; Teschler H; Stamatis G; Wagner H; Passlick B; Petersen V; Budach V; Wilhelm H; Wanke I; Hirche H; Wilke HJ; Stuschke M J Clin Oncol; 2007 Nov; 25(31):4987-92. PubMed ID: 17971598 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]